The IRE+CpG/pIC/PD-L1-Ab ablation which we previously demonstrated was able to eradicate EG7 lymphoma (23) failed to eliminate 3LLOVA lung cancer, though tumor growth was significantly inhibited and mouse survival was markedly prolonged (Figures 2D, E). The gene discussed is CD274; the disease is lymphoma.